Rapid Genome-wide Testing: Clinical Utility and Cost-Effectiveness

Details

Files
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1390-000

Question

  1. What is the clinical utility of providing rapid turnaround for genome-wide testing for patients in intensive care?
  2. What is the cost-effectiveness of providing rapid turnaround for genome-wide testing for patients in intensive care?
  3. What are the evidence-based guidelines of providing rapid turnaround for genome-wide testing for patients in intensive care?

Key Message

​One randomized controlled trial and three non-randomized studies were identified regarding the clinical utility of providing rapid turnaround for genome-wide testing for patients in intensive care. No relevant economic evaluations or evidence-based guidelines were identified